Professional corporation

Amarin Partner EddingPharm Receives Regulatory Approval for Vascepa® (Icosapent Ethyl) in Mainland China

Retrieved on: 
Thursday, June 1, 2023

DUBLIN, Ireland and BRIDGEWATER, N.J., June 01, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that its commercial partner in China, EddingPharm (EDDING), has received regulatory approval for VASCEPA® (icosapent ethyl) from China’s National Medical Products Administration (NMPA). NMPA granted approval for VASCEPA as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia (≥500 mg/dL).

Key Points: 
  • DUBLIN, Ireland and BRIDGEWATER, N.J., June 01, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that its commercial partner in China, EddingPharm (EDDING), has received regulatory approval for VASCEPA® (icosapent ethyl) from China’s National Medical Products Administration (NMPA).
  • NMPA granted approval for VASCEPA as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia (≥500 mg/dL).
  • Following regulatory approval, EDDING is now focusing on National Reimbursement Drug Listing (NRDL) and preparing for commercial launch in China, expected by year-end, as well as on advancing regulatory submission and review for an additional indication in cardiovascular risk reduction (CVRR).
  • Following the NMPA approval for this indication, Amarin is now entitled to receive a regulatory milestone payment of $5 million.

Amarin to Present at Two Upcoming Investor Conferences

Retrieved on: 
Thursday, June 1, 2023

DUBLIN, Ireland and BRIDGEWATER, N.J., June 01, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that Aaron Berg, Amarin’s Interim President and Chief Executive Officer and Tom Reilly, Amarin’s Chief Financial Officer, will present at two upcoming investor conferences:

Key Points: 
  • DUBLIN, Ireland and BRIDGEWATER, N.J., June 01, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that Aaron Berg, Amarin’s Interim President and Chief Executive Officer and Tom Reilly, Amarin’s Chief Financial Officer, will present at two upcoming investor conferences:
    Jefferies Healthcare Conference (June 7-9, 2023; New York, New York)
    Goldman Sachs 44th Annual Global Healthcare Conference (June 12-15, 2023; Dana Point, California)

Hess Celebrates the Mini Toy Truck's 25th Silver Anniversary

Retrieved on: 
Thursday, June 1, 2023

In celebration of this silver anniversary of the Hess Mini Toy Truck series, customers will be entered into the Silver Sweeps – where 25 lucky winners will receive a rare silver-colored version of the Mini Collection.

Key Points: 
  • In celebration of this silver anniversary of the Hess Mini Toy Truck series, customers will be entered into the Silver Sweeps – where 25 lucky winners will receive a rare silver-colored version of the Mini Collection.
  • Hess Corporation released a special edition 25th Anniversary Mini Toy Truck Collection, exclusively at HessToyTruck.com.
  • Introduced in 1998, the annual release of the Hess Mini is a limited-production set of highly detailed, small-scale versions of classic holiday Hess Toy Trucks.
  • This year's special set pays tribute to three different Hess anniversary toys: the 2014 Hess Collector's Edition Tanker which celebrated the 50th anniversary of the Hess Toy Truck, the 2014 50th Anniversary holiday Toy Truck and Space Cruiser, and the 2018 Collector's Edition First Hess Truck, which commemorated Hess Corporation's 85th anniversary.

Dr. Burkhard Blank Joins MannKind as Executive Vice President of Research & Development and Chief Medical Officer

Retrieved on: 
Wednesday, May 24, 2023

DANBURY, Conn., May 24, 2023 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products and devices for patients with endocrine and orphan lung diseases, announced Burkhard Blank, MD, has joined the company as Executive Vice President, Research & Development and Chief Medical Officer, effective today.

Key Points: 
  • DANBURY, Conn., May 24, 2023 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products and devices for patients with endocrine and orphan lung diseases, announced Burkhard Blank, MD, has joined the company as Executive Vice President, Research & Development and Chief Medical Officer, effective today.
  • Blank will report directly to Michael Castagna, PharmD, Chief Executive Officer, and will serve on the company’s executive leadership team.
  • “Burkhard is an accomplished R&D leader and CMO whose experience will be beneficial as we continue to drive our pipeline and future growth,” said Dr. Castagna.
  • Dr. Blank recently served as CMO/Head of R&D at Pharnext SA after serving seven years in the same position at Acorda Therapeutics.

Roquette Announces Strategic Investment and Innovation Agreement with Beren Therapeutics P.B.C.

Retrieved on: 
Tuesday, May 23, 2023

Roquette, a leading provider of pharmaceutical excipients and global leader in plant-based ingredients, is pleased to announce a strategic investment with Beren Therapeutics P.B.C., and the launch of an innovation agreement to expand the full potential of Beren’s cyclodextrin technologies and their medicinal applications.

Key Points: 
  • Roquette, a leading provider of pharmaceutical excipients and global leader in plant-based ingredients, is pleased to announce a strategic investment with Beren Therapeutics P.B.C., and the launch of an innovation agreement to expand the full potential of Beren’s cyclodextrin technologies and their medicinal applications.
  • View the full release here: https://www.businesswire.com/news/home/20230523005131/en/
    Beren is a vertically integrated biopharmaceutical company focused on addressing the world’s most significant health challenges.
  • Roquette recognizes the revolutionary potential of Beren’s research to transform the market and the lives of millions of patients worldwide.
  • To learn more about Roquette’s latest strategic partnerships and its wider cyclodextrins portfolio, visit: www.roquette.com .

ARCH Venture Partners Announces Appointment of Kevin Hrusovsky as Venture Partner

Retrieved on: 
Thursday, May 25, 2023

CHICAGO, May 25, 2023 /PRNewswire/ -- ARCH Venture Partners today announced the appointment of life sciences industry veteran Kevin Hrusovsky as Venture Partner.

Key Points: 
  • CHICAGO, May 25, 2023 /PRNewswire/ -- ARCH Venture Partners today announced the appointment of life sciences industry veteran Kevin Hrusovsky as Venture Partner.
  • "Kevin has been instrumental in the success of multiple ARCH portfolio companies, and we look forward to building the next generation of companies together," said ARCH Co-founder and Managing Director Keith Crandell.
  • "ARCH is committed to bringing the best entrepreneurs, experience, value-add perspective, and network to advance our portfolio companies.
  • Kevin has deep experience in the industry and is an important addition to the ARCH team."

DigitalBridge Announces PIF as an Investor in a New Partnership Aiming to Develop Data Centers in Saudi Arabia and the GCC Region

Retrieved on: 
Wednesday, May 24, 2023

BOCA RATON, Fla., May 24, 2023 /PRNewswire/ -- DigitalBridge Group, Inc. (NYSE: DBRG) ("DigitalBridge"), a leading global asset manager dedicated to investing in the next generation of mobile and internet connectivity, announced today that the Public Investment Fund ("PIF") is an investor in a new partnership managed by DigitalBridge, aiming to develop data centers in Saudi Arabia and across the Gulf Cooperation Council ("GCC").

Key Points: 
  • The partnership will initially prioritize investments in the data center sector, and is expected to explore other segments of digital infrastructure in the future, including macro towers, fiber, small cell, and edge infrastructure.
  • Partnering with DigitalBridge will support the enhancement of digital infrastructure in Saudi Arabia to the highest global standards, in line with PIF's strategy.
  • The investment aims to localize cutting-edge technologies and support knowledge transfer to develop and operate hyperscale data centers and database servers in Saudi Arabia and the GCC region, in accordance with the best practices in this vital sector which will help large local and international corporations to carry out their business in the region with greater efficiency.
  • "As a global leader in digital infrastructure, we are pleased to partner with PIF to further enable the digital infrastructure buildout in Saudi Arabia and across the GCC countries.

DigitalBridge Announces PIF as an Investor in a New Partnership Aiming to Develop Data Centers in Saudi Arabia and the GCC Region

Retrieved on: 
Wednesday, May 24, 2023

BOCA RATON, Fla., May 24, 2023 /PRNewswire/ -- DigitalBridge Group, Inc. (NYSE: DBRG) ("DigitalBridge"), a leading global asset manager dedicated to investing in the next generation of mobile and internet connectivity, announced today that the Public Investment Fund ("PIF") is an investor in a new partnership managed by DigitalBridge, aiming to develop data centers in Saudi Arabia and across the Gulf Cooperation Council ("GCC").

Key Points: 
  • The partnership will initially prioritize investments in the data center sector, and is expected to explore other segments of digital infrastructure in the future, including macro towers, fiber, small cell, and edge infrastructure.
  • Partnering with DigitalBridge will support the enhancement of digital infrastructure in Saudi Arabia to the highest global standards, in line with PIF's strategy.
  • The investment aims to localize cutting-edge technologies and support knowledge transfer to develop and operate hyperscale data centers and database servers in Saudi Arabia and the GCC region, in accordance with the best practices in this vital sector which will help large local and international corporations to carry out their business in the region with greater efficiency.
  • "As a global leader in digital infrastructure, we are pleased to partner with PIF to further enable the digital infrastructure buildout in Saudi Arabia and across the GCC countries.

EQS-News: Innolux to Showcase High-Value, Cross-Domain, Sustainable Products and Technologies at SID Display Week 2023

Retrieved on: 
Monday, May 22, 2023

MIAOLI, TAIWAN - Media OutReach - 22 May 2023 - Innolux is set to attend the SID Display Week 2023 (Booth# 313) in Los Angeles from May 23 to 25, 2023.

Key Points: 
  • MIAOLI, TAIWAN - Media OutReach - 22 May 2023 - Innolux is set to attend the SID Display Week 2023 (Booth# 313) in Los Angeles from May 23 to 25, 2023.
  • With the theme of "Make for Your Life," Innolux will exhibit a series of display technology applications in smart living.
  • Innolux's "Integrated automotive LID", the world's first-ever single-piece large curved display, is a front-seat display that maximizes information display.
  • Video featuring Innolux's SID products:
    Innolux SID 2023, Make For Your Life - Breakthrough Technologies:

Infinera Corporation Announces the Repurchase of Approximately $83.9M of Convertible Senior Notes Due 2024 using Proceeds from the Reopening of Convertible Senior Notes Due 2028

Retrieved on: 
Wednesday, May 17, 2023

Net proceeds from the issuance of the additional 2028 notes will be used to repurchase from certain investors approximately $83.9 million in aggregate principal amount of its currently outstanding 2024 notes.

Key Points: 
  • Net proceeds from the issuance of the additional 2028 notes will be used to repurchase from certain investors approximately $83.9 million in aggregate principal amount of its currently outstanding 2024 notes.
  • Following the closing of the transactions, approximately $18.7 million in aggregate principal amount of 2024 notes will remain outstanding with terms unchanged.
  • Infinera expects to use the remaining net proceeds from the reopening transaction to retire additional 2024 notes from time to time, including at their maturity, and for general corporate purposes.
  • HudsonWest LLC acted as sole placement agent in connection with the private placement of the additional 2028 notes.